Description

Their non-invasive, CE-certified (“drug-free”) method is designed to treat diabetic polyneuropathy and improve patients’ quality of life. The approach does not merely address consequences such as chronic wounds, but targets the underlying pathophysiological mechanism of diabetic foot, where impaired microcirculation prevents healing. Clinical studies have shown a significant improvement in symptoms of diabetic neuropathy and substantially faster wound healing, with wounds being up to 35 times more likely to heal within four weeks compared to standard treatment.

The device does not merely address symptoms but targets the underlying pathophysiological mechanism of the disease. It focuses on modern approaches to the treatment and management of complications associated with diabetes.

The medical device is certified as a Class II device and is already in use in clinical practice, where clinical studies have demonstrated a significant improvement in symptoms of diabetic neuropathy and substantially faster wound healing compared to standard treatment approaches.